accountfor BYETTA(R) (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes. Previously, it was approved for use only in patients...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes --Prescribing Information Also Includes Updated Safety Information
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
